Northbrook, IL, United States
Northbrook, IL, United States

Time filter

Source Type

Quasar PN Polycarbonate Prismatic Skylights revolutionize the high performance daylighting industry by providing the highest visible transmission with 100% diffusion in the industry with all the high impact and fire resistance benefits of polycarbonate. Santa Ana, CA, May 24, 2017 --( When it comes to energy efficiency, its all about the light. The U.S. Department of Energy has documented that there isn't a more cost effective solar energy saving option than utilizing high performance skylights with active daylighting controls in industrial/commercial building applications. Research has shown that maximizing visible light transmission while providing greater than 90% diffusion, produces the most hours annually that a skylight can replace the need for electric lighting at the optimum skylight to floor ratio, determined to be 5% or less. Polycarbonate has long been know as a top performer when it comes to impact and fire resistance. The Quasar PN Polycarbonate Prismatic Nanosphere is CC1, Class A fire rated as well as Factory Mutual rated against Class 4, 2" hail and comes with a 10 year hail proof warranty. By tilizing Quasar PN Polycarbonate Prismatic Nanosphere skylights for your daylighting measures, you don't have to give up building protection to get energy performance. Kingspan Light + Air is the newest division of Kingspan Group from Kingscourt, Ireland, a global provider of energy efficient building systems and known as the worlds largest manufacturer of insulated metal building panels. Kingspan Light + Air North America is the new name for Bristolite Daylighting Systems with over 40 years of producing the broadest line of skylight solutions. Kingspan Light + Air Globally is a 2000 employee, €200 million business focused on energy solutions in daylighting, LED, natural ventilation, and smoke and heat evacuation. For more information, please contact our North American Headquarters located in Santa Ana, California toll free at (800) 854-8618 or visit their website at Santa Ana, CA, May 24, 2017 --( PR.com )-- Kingspan Light + Air (the new name for Bristolite Daylighting Systems) has launched the Quasar PN high performance skylight utilizing the latest advancements in polycarbonate plastic coupled with prismatic glazing technology. Through the use of nanospheres embeded in extruded polycarbonate, coupled with prismatic polycarbonate glazing, Kingspan Light + Air has been able to design the highest visible light transmittance (VT) skylight with 100% diffusion available in the industry. The double glazed skylight utilizing the light capturing Triarch Dome shape has been tested under ASTM D1003 to provide 72% VT with 100% haze which provides better lighting performance even when compared to the competition's acrylic prismatic models.When it comes to energy efficiency, its all about the light. The U.S. Department of Energy has documented that there isn't a more cost effective solar energy saving option than utilizing high performance skylights with active daylighting controls in industrial/commercial building applications. Research has shown that maximizing visible light transmission while providing greater than 90% diffusion, produces the most hours annually that a skylight can replace the need for electric lighting at the optimum skylight to floor ratio, determined to be 5% or less. Polycarbonate has long been know as a top performer when it comes to impact and fire resistance. The Quasar PN Polycarbonate Prismatic Nanosphere is CC1, Class A fire rated as well as Factory Mutual rated against Class 4, 2" hail and comes with a 10 year hail proof warranty. By tilizing Quasar PN Polycarbonate Prismatic Nanosphere skylights for your daylighting measures, you don't have to give up building protection to get energy performance.Kingspan Light + Air is the newest division of Kingspan Group from Kingscourt, Ireland, a global provider of energy efficient building systems and known as the worlds largest manufacturer of insulated metal building panels. Kingspan Light + Air North America is the new name for Bristolite Daylighting Systems with over 40 years of producing the broadest line of skylight solutions. Kingspan Light + Air Globally is a 2000 employee, €200 million business focused on energy solutions in daylighting, LED, natural ventilation, and smoke and heat evacuation. For more information, please contact our North American Headquarters located in Santa Ana, California toll free at (800) 854-8618 or visit their website at www.kingspanlightandair.us Kingspan Light + Air North America Grant Grable 800-854-8618 www.kingspanlightandair.us Grant Grable is the Commercial Director of Kingspan Light + Air North America Click here to view the list of recent Press Releases from Kingspan Light + Air North America


Americas Gold Nanoparticles Market Information by Type (nanorods, nanoshells , nanocages) by Application (photodynamic therapy, diagnostics, medical imaging), by End-users (Hospitals, Clinics,Dental clinics) - Forecast to 2027Pune, India - April 25, 2017 /MarketersMedia/ — Market Scenario The market for Gold nanoparticles is increasing rapidly due to increasing advancement in nanotechnologies. The factors that influence the growth of Gold nanoparticles market; expanding medical diagnostics industry, increasing growth in advance healthcare technology, high advantages in medicinal imaging applications and many others. Key Players • Cytodiagnostics (Canada), • Goldsol (U.S), • NanoHybrids Corp (Austin), • Nanopartz Inc (U.S), • Nanosphere (Canada), • Nanostellar (U.S), • NanoRods LLC (U.S), • Sigma Aldrich (U.S), Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/1129 Segments On the basis of types • Nanorods • Nanoshells • Nanocages On the basis of application • Photodynamic therapy • Diagnostics • Medical imaging and others On the basis of End-users • Medical • Electronics • Catalysis Taste the market data and market information presented through more than 50 market data tables and figures spread in 120 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Americas Gold Nanoparticles Market Research Report - Forecast to 2027" Study Objectives of Gold nanoparticles • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Americas Gold nanoparticles market • To provide insights about factors affecting the market growth • To Analyze the Gold nanoparticles market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia, and Rest of the World (ROW) • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segment by Application, by End-users and its sub-segments. • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. The reports cover analysis Americas North America • US • Canada Latin America The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions. Related Reports Global Blood Transfusion Diagnostics Market Information by Type (Instruments, Reagents), By Application (Blood Grouping, disease Screening), By End users (Hospital, laboratories, Blood Banks, Plasma Fractionation Facilities) - Forecast to 2027.Know more about this report @ https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact Info:Name: Akash AnandEmail: akash.anand@marketresearchfuture.comOrganization: Market Research FutureAddress: Magarpatta Road, Hadapsar,Phone: 6468459349Source URL: http://marketersmedia.com/americas-gold-nanoparticles-market-key-players-analysis-cytodiagnostics-goldsol-nanohybrids-corp-nanopartz-inc-nanosphere-nanostellar-nanorods-llc/189913For more information, please visit https://www.marketresearchfuture.comSource: MarketersMediaRelease ID: 189913


The blood culture test market is categorized on the basis of methods, products, applications, end users, and regions. The global blood culture tests market is projected to reach USD 4,768.9 million by 2021 from USD 3,252.6 million in 2016, at a CAGR of 8.0%. Major factors contributing to the growth of this market include growing number of sepsis cases and high cost of treatment, increase in prevalence of infectious diseases, rapidly rising aging population, increase in product approvals and launches, increase in demand for rapid diagnostic techniques, and high incidence of bloodstream infections. Complete report on Blood Culture Tests Market spread across 249 Pages, Profiling 11 Companies and Supported with 300 Tables and 50 Figures is now available at http://www.reportsnreports.com/reports/377270-blood-culture-test-market-by-method-manual-automated-product-consumables-instrument-application-aerobic-anaerobic-yeast-fungi-end-user-hospital-reference-laboratory-clinical-laboratory-academic-research-institute-forecast-to-2019.html The relatively untapped Asian region provides an array of growth opportunities for blood culture test market. A large population base, rapid urbanization, increase in blood stream infection (BSI), rising prevalence of infectious diseases, rising aging population, increasing product availability, and technological advancements are some of the factors responsible for growth of this market. North America dominates the blood culture tests market in 2016, followed by Europe. However, Asia is projected to grow at the highest CAGR during the forecast period, owing to high incidence of sepsis and government initiatives to increase awareness on the disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis, increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region. Stakeholders of this Research Report are as follows Study suggests that Abbott’s PCR/ESI-MS can detect bacteria, viruses, or fungi in a short span of time when the blood culture tests market are negative. Such technological advancements will significantly contribute towards the adoption of rapid diagnostic techniques among hospital laboratories and reference laboratories, which are major end users of these instruments. Get the Sample Copy of this research In addition, the growth of the blood culture tests market in North America is driven by technological advancements and increase in demand for rapid diagnostic techniques. Various market players are focusing on new product launches to expand their product portfolios and cater to their wide customer base. Key players in the blood culture tests market include Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (U.S.), Cepheid, Inc. (U.S.), Nanosphere, Inc. (U.S.), Roche Diagnostics (Switzerland), Beckman Coulter (U.S.), Bruker Corporation (U.S.), IRIDICA (U.S.), and T2 Biosystems (U.S.). Click now for more Details, Queries, Other Information and Order this study “Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia) & End User (Hospital Laboratories, Reference Laboratories) - Global Forecast to 2021” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=377270 . Global blood culture tests market is dominated by North America, followed by Europe. However, market in Asia is expected to register the highest growth rate. Factors such as high incidence of sepsis and government initiatives to increase awareness on disease, increasing demand for effective diagnostic techniques, rising awareness about early disease diagnosis. Increasing adoption of advanced technologies, rapid rise in geriatric population, and growing regulatory approvals & availability of blood culture test products in this region are contributing to high growth rate of this market segment. Explore more reports on Healthcare at http://www.reportsnreports.com/market-research/healthcare/


News Article | December 2, 2016
Site: www.newsmaker.com.au

Wiseguyreports.Com Adds “Anti-Infective Drugs -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies Anti-Infective Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering By types, the market can be split into Antibiotic Antiviral Antifungal Others By Application, the market can be split into Hospital use Clinic Household Others By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Anti-Infective Drugs Market Professional Survey Report 2016 1 Industry Overview of Anti-Infective Drugs 1.1 Definition and Specifications of Anti-Infective Drugs 1.1.1 Definition of Anti-Infective Drugs 1.1.2 Specifications of Anti-Infective Drugs 1.2 Classification of Anti-Infective Drugs 1.2.1 Antibiotic 1.2.2 Antiviral 1.2.3 Antifungal 1.2.4 Others 1.3 Applications of Anti-Infective Drugs 1.3.1 Hospital use 1.3.2 Clinic 1.3.3 Household 1.3.4 Others 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 8 Major Manufacturers Analysis of Anti-Infective Drugs 8.1 GlaxoSmithKline 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Type I 8.1.2.2 Type II 8.1.2.3 Type III 8.1.3 GlaxoSmithKline 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 GlaxoSmithKline 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.2 Merck 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Type I 8.2.2.2 Type II 8.2.2.3 Type III 8.2.3 Merck 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Merck 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.3 Pfizer 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Type I 8.3.2.2 Type II 8.3.2.3 Type III 8.3.3 Pfizer 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Pfizer 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.4 Novartis AG 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Type I 8.4.2.2 Type II 8.4.2.3 Type III 8.4.3 Novartis AG 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Novartis AG 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.5 Gilead Sciences 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Type I 8.5.2.2 Type II 8.5.2.3 Type III 8.5.3 Gilead Sciences 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Gilead Sciences 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.6 Abbott 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Type I 8.6.2.2 Type II 8.6.2.3 Type III 8.6.3 Abbott 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Abbott 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.7 Wyeth 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Type I 8.7.2.2 Type II 8.7.2.3 Type III 8.7.3 Wyeth 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Wyeth 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.8 Sanofi-Aventis 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Type I 8.8.2.2 Type II 8.8.2.3 Type III 8.8.3 Sanofi-Aventis 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Sanofi-Aventis 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.9 Bristol-Myers Squibb 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Type I 8.9.2.2 Type II 8.9.2.3 Type III 8.9.3 Bristol-Myers Squibb 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Bristol-Myers Squibb 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.10 Johnson 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Type I 8.10.2.2 Type II 8.10.2.3 Type III 8.10.3 Johnson 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Johnson 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.11 Roche Pharma AG 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.2.1 Type I 8.11.2.2 Type II 8.11.2.3 Type III 8.11.3 Roche Pharma AG 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 Roche Pharma AG 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.12 Nanosphere 8.12.1 Company Profile 8.12.2 Product Picture and Specifications 8.12.2.1 Type I 8.12.2.2 Type II 8.12.2.3 Type III 8.12.3 Nanosphere 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.12.4 Nanosphere 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.13 NanoViricides 8.13.1 Company Profile 8.13.2 Product Picture and Specifications 8.13.2.1 Type I 8.13.2.2 Type II 8.13.2.3 Type III 8.13.3 NanoViricides 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.13.4 NanoViricides 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.14 Novabay Pharmaceuticals 8.14.1 Company Profile 8.14.2 Product Picture and Specifications 8.14.2.1 Type I 8.14.2.2 Type II 8.14.2.3 Type III 8.14.3 Novabay Pharmaceuticals 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.14.4 Novabay Pharmaceuticals 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.15 Obetech 8.15.1 Company Profile 8.15.2 Product Picture and Specifications 8.15.2.1 Type I 8.15.2.2 Type II 8.15.2.3 Type III 8.15.3 Obetech 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.15.4 Obetech 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.16 Optimer Pharmaceuticals 8.16.1 Company Profile 8.16.2 Product Picture and Specifications 8.16.2.1 Type I 8.16.2.2 Type II 8.16.2.3 Type III 8.16.3 Optimer Pharmaceuticals 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.16.4 Optimer Pharmaceuticals 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.17 Basilea Pharmaceutica AG 8.17.1 Company Profile 8.17.2 Product Picture and Specifications 8.17.2.1 Type I 8.17.2.2 Type II 8.17.2.3 Type III 8.17.3 Basilea Pharmaceutica AG 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.17.4 Basilea Pharmaceutica AG 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.18 Daiichi Sankyo 8.18.1 Company Profile 8.18.2 Product Picture and Specifications 8.18.2.1 Type I 8.18.2.2 Type II 8.18.2.3 Type III 8.18.3 Daiichi Sankyo 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.18.4 Daiichi Sankyo 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.19 MerLion Pharma 8.19.1 Company Profile 8.19.2 Product Picture and Specifications 8.19.2.1 Type I 8.19.2.2 Type II 8.19.2.3 Type III 8.19.3 MerLion Pharma 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.19.4 MerLion Pharma 2015 Anti-Infective Drugs Business Region Distribution Analysis 8.20 Theravance 8.20.1 Company Profile 8.20.2 Product Picture and Specifications 8.20.2.1 Type I 8.20.2.2 Type II 8.20.2.3 Type III 8.20.3 Theravance 2015 Anti-Infective Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.20.4 Theravance 2015 Anti-Infective Drugs Business Region Distribution Analysis


News Article | November 17, 2016
Site: www.newsmaker.com.au

MarketStudyReport.com adds “2016 Global Blood Culture Tests Market Status, 2011-2022 Market Historical and Forecasts, Professional Market Research Report” new report to its research database. The report spread across 139 pages with table and figures in it. This New Version Blood Culture Tests Market Research Report is a deep market research report in this market. This report focused on global and regional market, major manufacturers, as well as the segment market details on different classifications and applications. First, this report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy and news in Chapter 1. Second, the analysis on industry chain is provided including the up and down stream industry also with the major market players. And the analysis on manufacturing including process, cost structure and major plants distribution is conducted in Chapter 2. Then the global and regional market is analyzed. In these chapters, this report analyzed major market data like capacity, production, capacity utilization rate, price, revenue, cost, gross, gross margin, supply, import, export, consumption, market share, growth rate and etc. For regional market, this report analyzed major regions like Europe, North America, South America, Asia (Excluding China), China and ROW. These analysis are conducted in Chapter 3 and 4. In Chapter 5, the performance of major manufacturers are analyzed and then in Chapter 6 and 7 the analysis on major classification and application. Then the marketing channel analysis is provided including the major distributors in Chapter 8. Then this report analyzed the market forecast from 2017 to 2022 for global and regional market in Chapter 9 and the new project investment feasibility analysis in Chapter 10. At last, this report provided the conclusions of this research in Chapter 11. This report is a valuable source of guidance for manufacturers, suppliers, distributors, customers, investors and individuals who have interest in this market. Browse full table of contents and data tables at https://www.marketstudyreport.com/reports/2016-global-blood-culture-testsmarket-status-2011-2022-market-historical-and-forecasts-professional-market-research-report/ 5 Major Manufacturers Analysis 5.1 Becton, Dickinson and Company? 5.1.1 Company Profile 5.1.2 Product Specification 5.1.3 2011-2016 Global Market Performance 5.1.4 2015 Regional Market Performance 5.1.5 Contact Information 5.2 Biom?rieux SA? 5.2.1 Company Profile 5.2.2 Product Specification 5.2.3 2011-2016 Global Market Performance 5.2.4 2015 Regional Market Performance 5.2.5 Contact Information 5.3 Thermo Fisher Scientific, Inc.? 5.3.1 Company Profile 5.3.2 Product Specification 5.3.3 2011-2016 Global Market Performance 5.3.4 2015 Regional Market Performance 5.3.5 Contact Information 5.4 Cepheid? 5.4.1 Company Profile 5.4.2 Product Specification 5.4.3 2011-2016 Global Market Performance 5.4.4 2015 Regional Market Performance 5.4.5 Contact Information 5.5 Nanosphere, Inc.? 5.5.1 Company Profile 5.5.2 Product Specification 5.5.3 2011-2016 Global Market Performance 5.5.4 2015 Regional Market Performance 5.5.5 Contact Information 5.6 Bruker Corporation? 5.6.1 Company Profile 5.6.2 Product Specification 5.6.3 2011-2016 Global Market Performance 5.6.4 2015 Regional Market Performance 5.6.5 Contact Information 5.7 Beckman Coulter (Wholly Owned Subsidiary of Danaher Corporation)? 5.7.1 Company Profile 5.7.2 Product Specification 5.7.3 2011-2016 Global Market Performance 5.7.4 2015 Regional Market Performance 5.7.5 Contact Information 5.8 Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)? 5.8.1 Company Profile 5.8.2 Product Specification 5.8.3 2011-2016 Global Market Performance 5.8.4 2015 Regional Market Performance 5.8.5 Contact Information 5.9 Iridica (A Subsidiary of Abbott Laboratories)? 5.9.1 Company Profile 5.9.2 Product Specification 5.9.3 2011-2016 Global Market Performance 5.9.4 2015 Regional Market Performance 5.9.5 Contact Information 5.10 T2 Biosystems 5.10.1 Company Profile 5.10.2 Product Specification 5.10.3 2011-2016 Global Market Performance 5.10.4 2015 Regional Market Performance 5.10.5 Contact Information 5.11 5.11.1 Company Profile 5.11.2 Product Specification 5.11.3 2011-2016 Global Market Performance 5.11.4 2015 Regional Market Performance 5.11.5 Contact Information 5.12 5.12.1 Company Profile 5.12.2 Product Specification 5.12.3 2011-2016 Global Market Performance 5.12.4 2015 Regional Market Performance 5.12.5 Contact Information To receive personalized assistance write to us @ [email protected] with the report title in the subject line along with your questions or call us at +1 866-764-2150


Patent
Nanosphere | Date: 2012-12-18

The invention relates to methods for detecting complexes of Tau, Tau variants, including phosphorylated variants, and amyloid containing molecules, as well as autoantibodies to those complexes or components of those complexes, in physiological fluid samples.


An apparatus and method for imaging metallic nanoparticles is provided. Preferably, the invention provides for an apparatus and method for detection of gold colloid particles and for accurate reporting to the operator. The apparatus includes a substrate holder for holding the substrate, a processor and memory device, an imaging module, an illumination module, a power module, an input module, and an output module. The apparatus may have a stationary substrate holder and imaging module which are proximate to one another. The apparatus provided for a compact sized system without the need for complex motorized devices to move the camera across the substrate. Further, the apparatus and method provide for automatic detection of the spots/wells on the substrate, automatic quantification of the spots on the substrate, and automatic interpretation of the spots based on decision statistics.


This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.


A method includes applying ultrasound to a container having a plurality of magnetic particles contacted with a fluid sample having a biological material capable of binding to the magnetic particles, in an amount effective to suspend the magnetic particles in the fluid.


Patent
Nanosphere | Date: 2015-04-22

Disclosed are cartridges and modules that may be utilized in diagnostic systems and methods. The cartridge includes a flexible seal that caps the cartridge. The flexible seal has an opening for a pipette tip, and the flexible seal is configured to create a sealed environment when a pipette tip is positioned in the opening of the flexible seal and when the pipette tip is moved in the X-axis, Y-axis, and Z-axis.

Loading Nanosphere collaborators
Loading Nanosphere collaborators